Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells-Reference-Cited by-同舟云学术

Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells

Published:2010-03-12 Issue:5 Volume:160 Page:1144-1157
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Czyz M,Lesiak-Mieczkowska K,Koprowska K,Szulawska-Mroczek A,Wozniak M

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.2010.00749.x/fullpdf

Reference51 articles.

1. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls;Baud;Nat Rev Drug Discov,2009

2. The role of parthenolide in intracellular signalling processes: review of current knowledge;Bedoya;Curr Sign Transd Ther,2008

3. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB;Bork;FEBS Lett,1997

4. Malignant melanoma: genetics and therapeutics in the genomic era;Chin;Genes Dev,2006

5. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells;Cory;Anticancer Res,2002

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological effects of volatile oil from chrysanthemum and its associated mechanisms: a review;Acupuncture and Herbal Medicine;2024-01-17

2. A novel nanoformulation of parthenolide coated with polydopamine shows selective cytotoxicity and induces apoptosis in gastric cancer cells;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-18

3. The polypharmacology of natural products in drug discovery and development;Annual Reports in Medicinal Chemistry;2023

4. Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents;Chinese Journal of Natural Medicines;2022-11

5. ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via MEK4/MAPK pathway;Acta Pharmacologica Sinica;2022-01-26